{"id":"placebo-prednisolone","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Hyperglycemia / glucose intolerance"},{"rate":"5-20","effect":"Hypertension"},{"rate":"variable with duration","effect":"Osteoporosis / bone loss"},{"rate":"variable","effect":"Immunosuppression / increased infection risk"},{"rate":"5-15","effect":"Insomnia / mood changes"},{"rate":"10-20","effect":"Weight gain / fluid retention"},{"rate":"5-10","effect":"Gastrointestinal upset"}]},"_chembl":{"chemblId":"CHEMBL1201014","moleculeType":"Small molecule","molecularWeight":"484.39"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Prednisolone is a synthetic glucocorticoid that enters cells and binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene expression. This results in decreased production of inflammatory mediators (cytokines, chemokines, adhesion molecules) and suppression of immune cell activation and proliferation. The term 'Placebo Prednisolone' suggests this may refer to a placebo-controlled formulation or study arm rather than an active drug product.","oneSentence":"Prednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:01:20.168Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis)"},{"name":"Allergic reactions and asthma"},{"name":"Adrenal insufficiency"},{"name":"Certain hematologic malignancies and lymphomas"}]},"trialDetails":[{"nctId":"NCT05462730","phase":"PHASE2","title":"Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"Thomas Engstrom","startDate":"2022-11-14","conditions":"ST Elevation Myocardial Infarction, Inflammatory Response, Myocardial Reperfusion Injury","enrollment":530},{"nctId":"NCT05139316","phase":"PHASE3","title":"A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)","status":"COMPLETED","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2021-11-08","conditions":"Glycogen Storage Disease Type IA","enrollment":49},{"nctId":"NCT07255248","phase":"PHASE4","title":"Hoffa's Fat Pad Impingement (HFPI)","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2026-03-01","conditions":"Hoffa's Fat Pad Impingement","enrollment":62},{"nctId":"NCT07478003","phase":"PHASE3","title":"Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial","status":"NOT_YET_RECRUITING","sponsor":"Thomas Engstrom","startDate":"2026-04-01","conditions":"STEMI - ST Elevation Myocardial Infarction","enrollment":5204},{"nctId":"NCT05435781","phase":"PHASE4","title":"Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency","status":"RECRUITING","sponsor":"Marianne Christina Klose","startDate":"2022-06-07","conditions":"Adrenal Insufficiency, Polymyalgia Rheumatica, Giant Cell Arteritis","enrollment":250},{"nctId":"NCT06585774","phase":"PHASE3","title":"A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease","status":"RECRUITING","sponsor":"Incyte Corporation","startDate":"2025-01-21","conditions":"Chronic Graft-versus-host-disease","enrollment":240},{"nctId":"NCT05171816","phase":"PHASE3","title":"Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-24","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":110},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT06952803","phase":"PHASE3","title":"A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-08-06","conditions":"Prostate Cancer","enrollment":700},{"nctId":"NCT05039619","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-05-12","conditions":"Lupus Nephritis","enrollment":40},{"nctId":"NCT04206553","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2020-10-28","conditions":"Bullous Pemphigoid","enrollment":106},{"nctId":"NCT06624670","phase":"PHASE3","title":"A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum","status":"RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2025-02-04","conditions":"Pyoderma Gangrenosum","enrollment":90},{"nctId":"NCT03644667","phase":"PHASE2","title":"Tocilizumab in Cardiac Transplantation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-12-20","conditions":"Heart Transplant","enrollment":385},{"nctId":"NCT05674994","phase":"PHASE3","title":"Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Fondation Hôpital Saint-Joseph","startDate":"2023-10-26","conditions":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":110},{"nctId":"NCT03725202","phase":"PHASE3","title":"A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2019-01-24","conditions":"Giant Cell Arteritis (GCA)","enrollment":429},{"nctId":"NCT04161898","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2020-02-04","conditions":"Takayasu Arteritis (TAK)","enrollment":56},{"nctId":"NCT05345171","phase":"PHASE3","title":"Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2022-10-18","conditions":"OTC Deficiency","enrollment":32},{"nctId":"NCT04221477","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2020-08-10","conditions":"Lupus Nephritis","enrollment":271},{"nctId":"NCT04918147","phase":"PHASE2","title":"Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-10-13","conditions":"IgG4 Related Disease, IgG4-RD","enrollment":8},{"nctId":"NCT07380152","phase":"PHASE1","title":"Corticosteroid Therapy in Pulmonary Sequelae of Covid-19","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2021-08-10","conditions":"COVID-19 Pulmonary Complications","enrollment":100},{"nctId":"NCT07258771","phase":"PHASE4","title":"Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis","status":"RECRUITING","sponsor":"Berinstein, Jeffrey","startDate":"2026-01-16","conditions":"Ulcerative Colitis Acute","enrollment":110},{"nctId":"NCT03732820","phase":"PHASE3","title":"Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2018-10-31","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":895},{"nctId":"NCT07371572","phase":"PHASE3","title":"The Efficacy and Safety of Intramuscular Methylprednisolone in Patients With Hand OsteoArthritis","status":"RECRUITING","sponsor":"Sint Maartenskliniek","startDate":"2025-10-28","conditions":"Hand Osteoarthritis","enrollment":212},{"nctId":"NCT05220319","phase":"PHASE4","title":"CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients","status":"COMPLETED","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2022-02-16","conditions":"Inflammatory Response, Weakness, Muscle","enrollment":751},{"nctId":"NCT04493853","phase":"PHASE3","title":"Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2020-07-13","conditions":"Hormone-Sensitive Prostate Cancer","enrollment":1012},{"nctId":"NCT07353749","phase":"PHASE4","title":"Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms","status":"NOT_YET_RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2026-01-30","conditions":"Unruptured Intracranial Aneurysms, Cerebrovascular Event, Hemorrhagic Stroke","enrollment":864},{"nctId":"NCT03875690","phase":"PHASE3","title":"Benefit of a Flash Dose of Corticosteroids in Digestive Surgical Oncology: a Randomized, Double Blind, Placebo-controlled Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2019-07-02","conditions":"Elective Surgery for Any Digestive Cancer","enrollment":1200},{"nctId":"NCT06956482","phase":"PHASE3","title":"PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-02","conditions":"Alcoholic Hepatitis","enrollment":477},{"nctId":"NCT07348627","phase":"PHASE3","title":"Opioid-Sparing Joint Replacement","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Pain Management, Opioid Consumption","enrollment":120},{"nctId":"NCT05776459","phase":"PHASE2","title":"Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AudioCure Pharma GmbH","startDate":"2022-10-13","conditions":"Hearing Loss, Sensorineural","enrollment":210},{"nctId":"NCT05058287","phase":"PHASE3","title":"Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-11-05","conditions":"Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative","enrollment":150},{"nctId":"NCT07328906","phase":"NA","title":"Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome","status":"NOT_YET_RECRUITING","sponsor":"University of Belgrade","startDate":"2026-01","conditions":"Postimplantation Syndrome, Myocardial Injury, MACE","enrollment":174},{"nctId":"NCT04963296","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2021-10-26","conditions":"Systemic Lupus Erythematosus","enrollment":303},{"nctId":"NCT03229538","phase":"PHASE3","title":"STeroids to REduce Systemic Inflammation After Infant Heart Surgery","status":"COMPLETED","sponsor":"Kevin Hill","startDate":"2017-10-18","conditions":"Congenital Heart Disease in Children, Inflammatory Response","enrollment":1263},{"nctId":"NCT02281929","phase":"PHASE3","title":"Efficacy of Antibiotic Therapy in Severe Alcoholic Hepatitis Treated With Prednisolone","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2015-06-13","conditions":"Alcoholic Hepatitis, Alcoholic Liver Disease","enrollment":297},{"nctId":"NCT05201469","phase":"PHASE2","title":"VIBRANT: VIB4920 for Active Lupus Nephritis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-05-16","conditions":"Lupus Nephritis","enrollment":74},{"nctId":"NCT05619653","phase":"PHASE3","title":"Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valentina Puentmann","startDate":"2022-12-12","conditions":"COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular","enrollment":279},{"nctId":"NCT07267650","phase":"NA","title":"iPACK Block vs. Periarticular Infiltration for TKA Pain Control","status":"NOT_YET_RECRUITING","sponsor":"Turgutlu State Hospital","startDate":"2026-01-01","conditions":"Pain, Postoperative, Osteoarthritis, Knee / Osteoarthritis, Hip","enrollment":100},{"nctId":"NCT07091175","phase":"PHASE2","title":"Dupilumab Therapy in Nephrotic Syndrome in Children","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-11-27","conditions":"Nephrotic Syndrome in Children, Nephrotic Syndrome Steroid-Dependent","enrollment":66},{"nctId":"NCT05643638","phase":"PHASE2","title":"A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD","status":"RECRUITING","sponsor":"Cynata Therapeutics Limited","startDate":"2024-03-04","conditions":"Graft Versus Host Disease, Acute","enrollment":60},{"nctId":"NCT05190770","phase":"PHASE2","title":"A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-12-15","conditions":"Breast Cancer, Breast Cancer Stage, Breast Cancer Stage I","enrollment":18},{"nctId":"NCT06360458","phase":"PHASE3","title":"Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wan-Jin Chen","startDate":"2024-08-01","conditions":"Acute Ischemic Stroke, Large Infarct Core","enrollment":928},{"nctId":"NCT07252271","phase":"PHASE4","title":"Very Low Dose Prednisolone on Newly Diagnosed Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-12-01","conditions":"Rhematoid Arthritis","enrollment":112},{"nctId":"NCT04701034","phase":"PHASE2","title":"Intravenous Immunoglobulin and Prednisolone for RPL After ART.","status":"COMPLETED","sponsor":"Aalborg University Hospital","startDate":"2021-01-28","conditions":"Habitual Abortion, Recurrent Pregnancy Loss, Fertility Disorders","enrollment":80},{"nctId":"NCT05136976","phase":"PHASE3","title":"Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2023-06-29","conditions":"Anti-MAG Neuropathy","enrollment":90},{"nctId":"NCT05324748","phase":"PHASE3","title":"Repeated GON Injections in CCH","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2022-11-07","conditions":"Cluster Headache","enrollment":50},{"nctId":"NCT02433522","phase":"PHASE3","title":"Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-03-31","conditions":"ANCA-associated Vasculitides","enrollment":97},{"nctId":"NCT01748084","phase":"PHASE2, PHASE3","title":"Rituximab in Systemic Sclerosis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2013-04-09","conditions":"Systemic Sclerosis","enrollment":22},{"nctId":"NCT06298383","phase":"NA","title":"The Effect of Three Different Medications on Anesthetic Success and Postoperative Pain","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-06-15","conditions":"Symptomatic Irreversible Pulpitis","enrollment":120},{"nctId":"NCT06841705","phase":"PHASE2","title":"Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial","status":"RECRUITING","sponsor":"Shilpa Grover, MD, MPH","startDate":"2025-07-15","conditions":"Immune Checkpoint Inhibitor-Related Colitis","enrollment":80},{"nctId":"NCT04843761","phase":"PHASE3","title":"ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-04-20","conditions":"Covid19","enrollment":473},{"nctId":"NCT03584516","phase":"PHASE2, PHASE3","title":"GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease","status":"TERMINATED","sponsor":"Incyte Corporation","startDate":"2019-01-17","conditions":"Chronic Graft-versus-host Disease","enrollment":155},{"nctId":"NCT06143891","phase":"PHASE3","title":"A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-01-23","conditions":"Chronic Graft Versus Host Disease","enrollment":260},{"nctId":"NCT06729593","phase":"PHASE3","title":"Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-04-20","conditions":"Covid19","enrollment":87},{"nctId":"NCT06729606","phase":"PHASE3","title":"Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-04-20","conditions":"Covid19","enrollment":471},{"nctId":"NCT07210008","phase":"PHASE3","title":"\"Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis\"","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-06-01","conditions":"Hypersensitivity Pneumonitis","enrollment":120},{"nctId":"NCT07202143","phase":"PHASE3","title":"Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia","status":"RECRUITING","sponsor":"YiLin","startDate":"2025-09-01","conditions":"Large Infarct Core, Post-stroke Lymphocytopenia","enrollment":200},{"nctId":"NCT07141303","phase":"PHASE3","title":"Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-08-08","conditions":"Acute Ischemic Stroke","enrollment":1060},{"nctId":"NCT07180277","phase":"PHASE4","title":"Methylprednisolone for Moderate to Severe Traumatic Brain Injury","status":"NOT_YET_RECRUITING","sponsor":"Zhangjiagang First People's Hospital","startDate":"2025-10-01","conditions":"Traumatic Brain Injury","enrollment":520},{"nctId":"NCT07175649","phase":"NA","title":"Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STroke","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-10","conditions":"Ischemic Stroke, Acute","enrollment":912},{"nctId":"NCT00804531","phase":"PHASE4","title":"Intra-discal Steroid Injection for MODIC I Discopathy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2009-04","conditions":"Back Pain Lower Back Chronic","enrollment":137},{"nctId":"NCT03775460","phase":"NA","title":"Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum","status":"ACTIVE_NOT_RECRUITING","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2023-01-15","conditions":"Erythema Nodosum Leprosum","enrollment":550},{"nctId":"NCT04824092","phase":"PHASE3","title":"Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Incyte Corporation","startDate":"2021-05-11","conditions":"Diffuse Large B-cell Lymphoma","enrollment":899},{"nctId":"NCT03139604","phase":"PHASE3","title":"GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2017-07-19","conditions":"Graft-versus-host Disease (GVHD)","enrollment":439},{"nctId":"NCT06446245","phase":"PHASE2","title":"Adjunctive Doxycycline for Central Nervous System Tuberculosis","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-08-21","conditions":"Tuberculosis, Meningeal, Tuberculosis; Meningitis (Etiology), Tuberculosis, Central Nervous System","enrollment":200},{"nctId":"NCT06471465","phase":"PHASE3","title":"Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases","status":"RECRUITING","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2025-04-29","conditions":"Radionecrosis of Brain, Brain Metastases","enrollment":84},{"nctId":"NCT07116811","phase":"PHASE3","title":"Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-01","conditions":"Vestibular Schwannoma, Facial Nerve Paralysis","enrollment":364},{"nctId":"NCT07112456","phase":"PHASE2","title":"Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations","status":"NOT_YET_RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2026-09-01","conditions":"Asthma Acute, Asthma Attack, Asthma Exacerbations","enrollment":100},{"nctId":"NCT07101367","phase":"PHASE1, PHASE2","title":"A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2025-09-01","conditions":"Coronary Artery Disease, Systemic Inflammatory Response Syndrome, Postoperative Complications","enrollment":60},{"nctId":"NCT05150704","phase":"PHASE3","title":"MYTHS - MYocarditis THerapy With Steroids","status":"RECRUITING","sponsor":"Niguarda Hospital","startDate":"2021-10-07","conditions":"Myocarditis Acute","enrollment":288},{"nctId":"NCT05570409","phase":"PHASE2, PHASE3","title":"Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy","status":"TERMINATED","sponsor":"LMU Klinikum","startDate":"2023-03-28","conditions":"Inflammatory Cardiomyopathy","enrollment":9},{"nctId":"NCT04979650","phase":"PHASE2","title":"Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2021-05-22","conditions":"Multiple Sclerosis, Relapsing-Remitting, Magnetic Resonance Imaging, Methylprednisolone","enrollment":102},{"nctId":"NCT04372615","phase":"PHASE2","title":"The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis","status":"RECRUITING","sponsor":"University of Utah","startDate":"2022-03-30","conditions":"Autoimmune Encephalitis, Encephalitis","enrollment":116},{"nctId":"NCT05288166","phase":"PHASE3","title":"A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2022-04-14","conditions":"Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms","enrollment":925},{"nctId":"NCT05819541","phase":"PHASE2","title":"Treating Exacerbations of Asthma With Oral Montelukast in Children","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-10-20","conditions":"Status Asthmaticus","enrollment":90},{"nctId":"NCT04921189","phase":"PHASE2","title":"Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2021-12-31","conditions":"Out-Of-Hospital Cardiac Arrest, Postcardiac Arrest Syndrome","enrollment":160},{"nctId":"NCT03072238","phase":"PHASE3","title":"Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-06-30","conditions":"Metastatic Prostate Cancer","enrollment":1101},{"nctId":"NCT05436652","phase":"PHASE2","title":"A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)","status":"COMPLETED","sponsor":"Sparrow Pharmaceuticals","startDate":"2022-07-22","conditions":"Polymyalgia Rheumatica","enrollment":66},{"nctId":"NCT06819670","phase":"PHASE2","title":"A Study to Prevent Infantile Spasms Relapse","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-05-05","conditions":"Infantile Spasms, Infantile Epileptic Spasms Syndrome, West Syndrome","enrollment":40},{"nctId":"NCT04177433","phase":"PHASE4","title":"The Use of Intra-articular Corticosteroid Injection to Treat Osteoarthritis of the Carpometacarpal Joint","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alberta","startDate":"2020-12-02","conditions":"Osteoarthritis of the Carpometacarpal Joint, Thumb Osteoarthritis","enrollment":90},{"nctId":"NCT05097976","phase":"PHASE4","title":"Medrol Dosepak for Outpatient Total Knee Arthroplasty","status":"RECRUITING","sponsor":"Rush University Medical Center","startDate":"2022-03-01","conditions":"Total Knee Arthroplasty","enrollment":420},{"nctId":"NCT05698680","phase":"PHASE4","title":"Prednisolone Versus Colchicine for Acute Gout in Primary Care","status":"RECRUITING","sponsor":"University Medicine Greifswald","startDate":"2023-01-18","conditions":"Acute Gout","enrollment":314},{"nctId":"NCT05974462","phase":"PHASE3","title":"MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction)","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2024-05-24","conditions":"Acute Myocarditis","enrollment":174},{"nctId":"NCT06925698","phase":"PHASE3","title":"Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease","status":"NOT_YET_RECRUITING","sponsor":"Marmara University","startDate":"2025-04-30","conditions":"Behcet Disease, Behcet Disease and Vascular Involvement, Deep Venous Thromboses","enrollment":110},{"nctId":"NCT06917859","phase":"PHASE1","title":"Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-02-01","conditions":"Cardiopulmonary Bypass, AKI - Acute Kidney Injury","enrollment":170},{"nctId":"NCT02288247","phase":"PHASE3","title":"A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone","status":"COMPLETED","sponsor":"Astellas Pharma Europe Ltd.","startDate":"2014-12-01","conditions":"Metastatic Castration Resistant Prostate Cancer","enrollment":688},{"nctId":"NCT06035081","phase":"NA","title":"CIRcadian Rhythms and CortisoL. Effects on Substrate Metabolism and Clock Gene Expression and Functioning","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2023-09-15","conditions":"Healthy","enrollment":10},{"nctId":"NCT05638633","phase":"PHASE3","title":"Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome","status":"COMPLETED","sponsor":"Wuerzburg University Hospital","startDate":"2022-11-11","conditions":"Post-COVID-19 Syndrome","enrollment":321},{"nctId":"NCT02785224","phase":"","title":"Arterial Pressure and Stress-Dose Steroids in Cardiac Arrest.","status":"WITHDRAWN","sponsor":"University of Athens","startDate":"2025-12","conditions":"Cardiac Arrest","enrollment":""},{"nctId":"NCT03194815","phase":"PHASE2","title":"IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2","status":"RECRUITING","sponsor":"University of Cambridge","startDate":"2017-11-01","conditions":"Psychosis, Autoimmune Encephalitis","enrollment":70},{"nctId":"NCT02004782","phase":"PHASE4","title":"Barretts oEsophageal Resection With Steroid Therapy Trial","status":"WITHDRAWN","sponsor":"Professor Michael Bourke","startDate":"2020-03-09","conditions":"Barrett Esophagus, Esophageal Stenosis","enrollment":""},{"nctId":"NCT06896253","phase":"PHASE2","title":"Pulse Corticosteroids Or/and Immunoglobulins to Treat Fulminant Myocarditis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-04","conditions":"Myocarditis Acute","enrollment":120},{"nctId":"NCT06870448","phase":"PHASE3","title":"Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-04","conditions":"Acute Ischemic Stroke","enrollment":1614},{"nctId":"NCT03781700","phase":"PHASE4","title":"Evaluation of Cortisone Treatment in Children With Acute Facial Nerve Palsy","status":"RECRUITING","sponsor":"Dalarna County Council, Sweden","startDate":"2019-05-03","conditions":"Facial Palsy, Facial Nerve Diseases, Borrelia Infection of Central Nervous System","enrollment":500},{"nctId":"NCT05986422","phase":"PHASE2","title":"Methylprednisolone in Patients with Cognitive Deficits in Post-COVID-19 Syndrome (PCS)","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2023-10-01","conditions":"Post-COVID-19 Syndrome","enrollment":418},{"nctId":"NCT02043678","phase":"PHASE3","title":"Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms","status":"COMPLETED","sponsor":"Bayer","startDate":"2014-03-30","conditions":"Prostatic Neoplasms","enrollment":806},{"nctId":"NCT06531018","phase":"PHASE1, PHASE2","title":"Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.","status":"RECRUITING","sponsor":"Renata PLC","startDate":"2025-02-07","conditions":"Primary Immune Thrombocytopenia","enrollment":100},{"nctId":"NCT05444699","phase":"PHASE4","title":"Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age","status":"RECRUITING","sponsor":"University of Oulu","startDate":"2022-10-11","conditions":"Bronchiolitis Acute Viral","enrollment":210},{"nctId":"NCT04072822","phase":"PHASE2","title":"Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis","status":"COMPLETED","sponsor":"Indiana University","startDate":"2020-07-10","conditions":"Alcoholic Hepatitis","enrollment":147},{"nctId":"NCT06623370","phase":"PHASE4","title":"The Effect of Methylprednisolone on the Reversal Time of Rocuronium by Sugammadex in the Pediatric Patient Group","status":"COMPLETED","sponsor":"Konya City Hospital","startDate":"2024-10-01","conditions":"Sugammadex Reversal Time, Muscle Weakness","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo","solupred","Orapred","oral corticosteroid","Predosone"],"phase":"marketed","status":"active","brandName":"Placebo Prednisolone","genericName":"Placebo Prednisolone","companyName":"Milton S. Hershey Medical Center","companyId":"milton-s-hershey-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Prednisolone is a corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production. Used for Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis), Allergic reactions and asthma, Adrenal insufficiency.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}